Literature DB >> 12446970

Tau, where are we now?

Gail V W Johnson1, Craig D C Bailey.   

Abstract

Tau is a multifunctional protein that was originally identified as a microtubule-associated protein. Tau is primarily a neuronal protein, but it is becoming increasingly evident that tau is present in non-neuronal cells where it also plays important roles. Tau is the primary protein component of the filaments (both paired helical and straight filaments) found in Alzheimer's disease brain. Further there is an ever growing family of neurodegenerative diseases called "tauopathies" where tau pathology is the primary, defining characteristic with little or no Abeta pathology. These findings, along with the fact that mutations in the tau gene cause a group of diseases collectively known as frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), clearly demonstrate that tau dysfunction results in neuronal dysfunction and death. This review highlights recent findings concerning the normal metabolism and function of tau, as well as the abnormal processing and function of tau in Alzheimer's disease and in the tauopathies, both sporadic and familial.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446970     DOI: 10.3233/jad-2002-4505

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  24 in total

1.  Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.

Authors:  Eric M Blalock; James W Geddes; Kuey Chu Chen; Nada M Porter; William R Markesbery; Philip W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

Review 2.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 3.  The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways.

Authors:  Eléonore Beurel; Richard S Jope
Journal:  Prog Neurobiol       Date:  2006-08-28       Impact factor: 11.685

4.  Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.

Authors:  Eric M Blalock; Heather M Buechel; Jelena Popovic; James W Geddes; Philip W Landfield
Journal:  J Chem Neuroanat       Date:  2011-07-02       Impact factor: 3.052

5.  Differential incorporation of tau isoforms in Alzheimer's disease.

Authors:  Marisol Espinoza; Rohan de Silva; Dennis W Dickson; Peter Davies
Journal:  J Alzheimers Dis       Date:  2008-05       Impact factor: 4.472

Review 6.  The roles of the proteasome pathway in signal transduction and neurodegenerative diseases.

Authors:  Jiao-Jiao Chen; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2008-06       Impact factor: 5.203

Review 7.  Neurodegenerative mutants in Drosophila: a means to identify genes and mechanisms involved in human diseases?

Authors:  Doris Kretzschmar
Journal:  Invert Neurosci       Date:  2005-10-24

8.  Disruption of the MAP1B-related protein FUTSCH leads to changes in the neuronal cytoskeleton, axonal transport defects, and progressive neurodegeneration in Drosophila.

Authors:  Alexandre Bettencourt da Cruz; Martin Schwärzel; Sabine Schulze; Mahtab Niyyati; Martin Heisenberg; Doris Kretzschmar
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

9.  Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.

Authors:  Shreyasi Chatterjee; Tzu-Kang Sang; George M Lawless; George R Jackson
Journal:  Hum Mol Genet       Date:  2008-10-17       Impact factor: 6.150

10.  High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation.

Authors:  David O Azorsa; RiLee H Robeson; Danielle Frost; Bessie Meec hoovet; Gillian R Brautigam; Chad Dickey; Christian Beaudry; Gargi D Basu; David R Holz; Joseph A Hernandez; Kristen M Bisanz; Leslie Gwinn; Andrew Grover; Joseph Rogers; Eric M Reiman; Michael Hutton; Dietrich A Stephan; Spyro Mousses; Travis Dunckley
Journal:  BMC Genomics       Date:  2010-01-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.